Dr. Reddy's Laboratories
Search results
Built on the foundation of caring for life, Cipla ensures access to quality & affordable medicines through 1500+ products across various therapeutic categories.
In September 2015, Cipla acquired InvaGen Pharmaceuticals and Exelan Pharmaceuticals, two American pharmaceutical companies, for 555 million dollars. [ 17 ] In 2019 Cipla entered digital therapeutics by partnering with Wellthy Therapeutics in India and Brandmed in South Africa .
Cipla is a leading pharmaceutical company that provides affordable medicine to patients across geographies. Over the last 8 decades, we have been fortifying our promise of ‘Caring for Life'.
Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the...
Built on the foundation of caring for life, Cipla ensures access to quality & affordable medicines through 1500+ products across various therapeutic categories.
Our Generics business in India has contributed 19% of the domestic pharmaceutical revenues with 4,000+ partners covering the entire country. The business operates within an extremely competitive environment in a highly fragmented market with 5,000+ pharmaceutical players.
Cipla is a leading pharmaceutical from India with presence across the world. It was established in 1935 as Chemical Industrial & Pharmaceutical Laboratories Ltd and changed to its current name in 1984. The company has a vast portfolio with more than 1,500 products in the market.
Aug 5, 2023 · In Cipla, India had got its first modern pharma company which would supply drugs to Indians. It was a swadeshi project which decades later Khwaja Abdul Hamied's son would turn into a battle machine against multinational drug companies, now known as Big Pharma.
Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. For 80 years, Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 150 countries.
Oct 27, 2023 · Total revenue from operations rose nearly 15% to 66.78 billion rupees, led by a 13.4% growth in its mainstay pharmaceutical business, said Cipla, which makes generic respiratory and cancer...
